Conroy Kevin T

Conroy Kevin T, President and CEO of Exact Sciences Corporation (EXAS), has demonstrated a clear selling bias in his insider transactions, with no recorded purchases across 29 reported trades. SEC Form 4 filings reveal total sales exceeding $38.1 million, all concentrated in EXAS shares. The most significant transaction occurred on December 23, 2025, when Conroy disposed of shares worth approximately $15.8 million. Additional sales followed in early 2026, including multiple transactions on February 25 and 27 totaling over $4.1 million combined—comprising individual sales of $640,976, $880,516, $1.08 million, and $1.35 million. Notably, a cluster of transactions on March 23, 2026, involved dispositions (coded "D") with no reported dollar value, suggesting they may represent non-monetary transfers or smaller transactions. Conroy’s activity is exclusively tied to Exact Sciences, with no diversification across other companies. The absence of any buy transactions—both historically and recently—indicates a consistent pattern of reducing his position in EXAS. While the filings do not specify whether these sales were pre-planned (such as 10b5-1 transactions), the volume and timing, particularly the December 2025 sale, represent a material reduction in holdings. The transactions provide a straightforward narrative: Conroy has systematically liquidated EXAS shares over time, with no offsetting purchases to suggest confidence in near-term appreciation. The lack of recent activity beyond March 2026 leaves open whether this trend will continue.